Chengdu StarRay Therapeutics Co., Ltd
Chengdu StarRay Therapeutics Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-30 | NCT07310355 |